Published in Immunology on March 16, 2010
Current trends in West Nile virus vaccine development. Expert Rev Vaccines (2014) 0.93
Vaccines in development against West Nile virus. Viruses (2013) 0.90
Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine (2013) 0.84
Vaccines for TB: Lessons from the Past Translating into Future Potentials. J Immunol Res (2015) 0.76
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol (2000) 6.57
Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis (2005) 6.09
Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med (2003) 4.95
A study of the ecology of West Nile virus in Egypt. Am J Trop Med Hyg (1956) 4.50
Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology (2002) 3.79
West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med (2006) 3.68
Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis (2003) 3.52
Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature (2005) 3.51
West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49
Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med (2003) 3.37
Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet (2001) 3.26
Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12
T cells against a bacterial heat shock protein recognize stressed macrophages. Science (1989) 2.79
A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods (1998) 2.79
Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol (2005) 2.70
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol (2002) 2.66
West Nile virus. Lancet Neurol (2007) 2.26
Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest (2007) 2.00
Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol (2005) 1.86
Migratory birds and West Nile virus. J Appl Microbiol (2003) 1.85
The molecular chaperone concept. Semin Cell Biol (1990) 1.80
West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol (1996) 1.79
Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem (2004) 1.66
Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus. Nat Biotechnol (2008) 1.64
The structural immunology of antibody protection against West Nile virus. Immunol Rev (2008) 1.63
West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am J Hyg (1954) 1.61
Ecological factors associated with West Nile virus transmission, northeastern United States. Emerg Infect Dis (2008) 1.47
Inflammation activates self hsp60-specific T cells. Eur J Immunol (1993) 1.27
Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology (2005) 1.26
Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol (2002) 1.23
Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J Biol Chem (2005) 1.23
West Nile virus: recent trends in diagnosis and vaccine development. Vaccine (2006) 1.19
Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One (2008) 1.16
Immunity to West Nile virus. Curr Opin Immunol (2004) 1.16
DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J Immunol (2003) 1.13
Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis (2009) 1.11
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus. Vaccine (2008) 1.10
Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA). J Med Virol (1985) 1.09
Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines (2008) 1.00
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol (2009) 0.97
Development of effective therapies against West Nile virus infection. Expert Rev Anti Infect Ther (2005) 0.95
The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization. Virus Res (2006) 0.91
Heat shock proteins in health and disease: therapeutic targets or therapeutic agents? Expert Rev Mol Med (2001) 0.90
T7 phage display of Ep15 peptide for the detection of WNV IgG. J Virol Methods (2007) 0.86
Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia (2002) 0.86
HSP60 speaks to the immune system in many voices. Novartis Found Symp (2008) 0.86
Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. J Immunol (1995) 0.85
Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. J Immunol (2003) 0.84
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine. Vaccine (2007) 0.84
Post-epidemic serosurvey of West Nile fever in Israel. Eur J Clin Microbiol Infect Dis (2005) 0.83
Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland. Vaccine (2005) 0.82
Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection. J Infect Dis (1999) 0.81
ChimeriVax-West Nile vaccine. Curr Opin Mol Ther (2007) 0.79
A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide. Vaccine (2006) 0.78
The molecular basis of antibody protection against West Nile virus. Curr Top Microbiol Immunol (2008) 0.78
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 6.54
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res (2008) 5.50
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol (2006) 5.00
Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis (2003) 3.52
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol (2006) 3.23
Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99
Simplicity belies a complex system: a response to the minimal model of immunity of Langman and Cohn. Cell Immunol (2002) 2.90
Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood (2006) 2.67
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol (2005) 2.55
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest (2006) 2.53
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood (2003) 2.06
Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest (2007) 2.00
Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol (2004) 1.71
Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A (2004) 1.69
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
Retracted Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest (2004) 1.58
T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. FASEB J (2006) 1.57
T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J (2003) 1.56
The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol (2009) 1.54
Emergent dynamics of thymocyte development and lineage determination. PLoS Comput Biol (2006) 1.49
Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation. Genome Res (2003) 1.48
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. PLoS One (2008) 1.47
Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol (2005) 1.44
Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol (2004) 1.43
The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct (2006) 1.41
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res (2011) 1.41
Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2005) 1.39
Retracted Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care (2014) 1.38
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol (2011) 1.37
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol (2005) 1.35
Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol (2006) 1.34
The HSP60 immune system network. Trends Immunol (2010) 1.33
Four-dimensional realistic modeling of pancreatic organogenesis. Proc Natl Acad Sci U S A (2008) 1.29
Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res (2009) 1.27
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol (2009) 1.27
Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol (2007) 1.24
Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol (2002) 1.23
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2002) 1.17
Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proc Natl Acad Sci U S A (2009) 1.14
RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity (2013) 1.14
DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J Immunol (2003) 1.13
Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry (2007) 1.12
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer (2008) 1.12
Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun (2004) 1.12
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology (2007) 1.12
Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis (2009) 1.11
Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J Immunol (2005) 1.09
H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol (2007) 1.08
An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08
Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. J Autoimmun (2003) 1.08
Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol (2002) 1.05
Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry (2005) 1.03
Killing of avian and Swine influenza virus by natural killer cells. J Virol (2010) 1.03
Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun (2007) 1.02
Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J Immunol (2005) 1.01
Propagation of lewis rat encephalitogenic T cell lines: T-cell-growth-factor is superior to recombinant IL-2. J Neuroimmunol (2002) 1.01
Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol (2011) 1.01
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood (2003) 1.00
Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol (2010) 1.00
The natural autoantibody repertoire and autoimmune disease. Biomed Pharmacother (2004) 0.98
Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae. J Infect Dis (2007) 0.98
Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses. Cell Microbiol (2004) 0.96
Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. J Immunol (2010) 0.96
HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest (2005) 0.96
DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol (2002) 0.96
Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients. Diabetes Metab Res Rev (2007) 0.95
The natural autoantibody repertoire in newborns and adults: a current overview. Adv Exp Med Biol (2012) 0.94
A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice. PLoS One (2009) 0.94
Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum (2004) 0.93
Expression of ligands to NKp46 in benign and malignant melanocytes. J Invest Dermatol (2007) 0.93
Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol (2008) 0.93
T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J Autoimmun (2003) 0.92
Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands. J Immunotoxicol (2012) 0.92
Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS One (2008) 0.92
Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection. PLoS One (2009) 0.92
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk. PLoS One (2011) 0.92
HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog (2010) 0.92
NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function. Ann N Y Acad Sci (2006) 0.91
Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One (2011) 0.91
NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol (2010) 0.91
Signaling via TLR2 and TLR4 Directly Down-Regulates T Cell Effector Functions: The Regulatory Face of Danger Signals. Front Immunol (2013) 0.90
Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J Virol (2009) 0.90
Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J Neurosci Res (2003) 0.89
Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice. Vaccine (2007) 0.89
NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice. PLoS One (2013) 0.87
HSP60 as a target of anti-ergotypic regulatory T cells. PLoS One (2008) 0.87
IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. J Immunol (2009) 0.87
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies. Immunology (2010) 0.86
D-enantiomer peptide of the TCRalpha transmembrane domain inhibits T-cell activation in vitro and in vivo. FASEB J (2005) 0.86
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis. Int Immunol (2006) 0.86
T7 phage display of Ep15 peptide for the detection of WNV IgG. J Virol Methods (2007) 0.86
HSP60 speaks to the immune system in many voices. Novartis Found Symp (2008) 0.86
Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling. J Leukoc Biol (2004) 0.85